pharma news

News

Olympic cyclist Chris Hoy praises cancer charity campaign

Sir Chris Hoy has said he is proud of participants in the Tour de 4 cycling event he set up last year to change perceptions of stage 4 cancer.

News

UK, pharma industry pilot rapid access routes for medicines

A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to patients more quickly.

News

Scribe Therapeutics joins the IPO queue

Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.

News

Trial of Bundibugyo Ebola drugs starts in DRC

Patients are now being enrolled in a trial of two potential therapies for Bundibugyo Ebola, Mapp's MBP134 and Gilead's remdesivir, says WHO.

News

Respiratory biotech Celea raises $180m, and other financings

This week's collection of venture capital financings in the biotech arena includes rounds for Celea, Beeline, Flare, Lycia, and Telum.

News

Newron charts course forward for stalled schizophrenia drug

Newron thinks it may have reached an agreement with the FDA on a way to get the US development of its schizophrenia candidate evenamide back on track.

Olympic cyclist Chris Hoy praises cancer charity campaign

UK, pharma industry pilot rapid access routes for medicines

Scribe Therapeutics joins the IPO queue

Trial of Bundibugyo Ebola drugs starts in DRC

Respiratory biotech Celea raises $180m, and other financings

Newron charts course forward for stalled schizophrenia drug

Gilead, MSD share data on once-weekly oral HIV treatment

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks